200 related articles for article (PubMed ID: 33529608)
21. Risk factors for developing medication-related osteonecrosis of the jaw when preserving the tooth that can be a source of infection in cancer patients receiving high-dose antiresorptive agents: a retrospective study.
Soutome S; Otsuru M; Murata M; Morishita K; Omori K; Suyama K; Hayashida S; Umeda M; Saito T
Support Care Cancer; 2022 Sep; 30(9):7241-7248. PubMed ID: 35587291
[TBL] [Abstract][Full Text] [Related]
22. Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study.
Wazzan T; Kashtwari D; Almaden WF; Gong Y; Chen Y; Moreb J; Katz J
Spec Care Dentist; 2018 Nov; 38(6):356-361. PubMed ID: 30194738
[TBL] [Abstract][Full Text] [Related]
23. Is serum C-terminal telopeptide cross-link of type 1 collagen a reliable parameter for predicting the risk of medication-related osteonecrosis of the jaws? A systematic review and meta-analysis of diagnostic test accuracy.
Traboulsi-Garet B; Jorba-García A; Camps-Font O; Alves FA; Figueiredo R; Valmaseda-Castellón E
Clin Oral Investig; 2022 Mar; 26(3):2371-2382. PubMed ID: 35124731
[TBL] [Abstract][Full Text] [Related]
24. Treatment outcomes and time to healing of medication-related osteonecrosis of the jaw based on image findings.
Yasui T; Nagamine H; Tanaka K; Kimura M; Karube T; Kawana H; Onizawa K
Dentomaxillofac Radiol; 2023 Jul; 52(5):20220352. PubMed ID: 37192041
[TBL] [Abstract][Full Text] [Related]
25. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
Hauer L; Jambura J; Hrusak D; Chalupova M; Posta P; Rusnak S; Vyskocil V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474
[TBL] [Abstract][Full Text] [Related]
26. A population based study of multiple myeloma patients with medication-related osteonecrosis of the jaw.
Auzina D; Slaidina A; Sevastjanova M; Erts R; Lejnieks A; Lejniece S
Stomatologija; 2019; 21(1):13-17. PubMed ID: 31619658
[TBL] [Abstract][Full Text] [Related]
27. Medication-Related Osteonecrosis of the Jaws: Two Center Retrospective Cohort Studies.
Petrovic M; Jelovac DB; Antic S; Antunovic M; Lukic N; Sabani M; Mudrak J; Jezdic Z; Pucar A; Stefanovic A; Kuzmanovic C; Nikolic D; Konstantinovic V
Biomed Res Int; 2019; 2019():8345309. PubMed ID: 31011580
[TBL] [Abstract][Full Text] [Related]
28. What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review.
Aljohani S; Fliefel R; Ihbe J; Kühnisch J; Ehrenfeld M; Otto S
J Craniomaxillofac Surg; 2017 Sep; 45(9):1493-1502. PubMed ID: 28687467
[TBL] [Abstract][Full Text] [Related]
29. Medication related osteonecrosis of the jaws (MRONJ): Factors related to recurrence after treatment with surgery and platelet rich plasma (PRP) placement.
Sánchez-Gallego Albertos C; Del Castillo Pardo de Vera JL; Viejo Llorente A; Cebrián Carretero JL
Med Oral Patol Oral Cir Bucal; 2021 Nov; 26(6):e684-690. PubMed ID: 34704981
[TBL] [Abstract][Full Text] [Related]
30. A retrospective study on the incidence of medication-related osteonecrosis of the jaws (MRONJ) associated with different preventive dental care modalities.
Bacci C; Cerrato A; Bardhi E; Frigo AC; Djaballah SA; Sivolella S
Support Care Cancer; 2022 Feb; 30(2):1723-1729. PubMed ID: 34580783
[TBL] [Abstract][Full Text] [Related]
31. Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ).
Pichardo SEC; van der Hee JG; Fiocco M; Appelman-Dijkstra NM; van Merkesteyn JPR
Br J Oral Maxillofac Surg; 2020 Sep; 58(7):771-776. PubMed ID: 32631756
[TBL] [Abstract][Full Text] [Related]
32. Medication-related osteonecrosis of the maxilla: Prognosis of oral surgery combined with endoscopic sinus surgery.
Park JH; Alfafara AM; Park YL; Bae JH; Kim SJ
Oral Dis; 2021 May; 27(4):962-969. PubMed ID: 32810362
[TBL] [Abstract][Full Text] [Related]
33. A multicenter observational study on Medication-Related Osteonecrosis of the Jaw (MRONJ) in advanced cancer and myeloma patients of a cancer network in North-Western Italy.
Fusco V; Cabras M; Erovigni F; Dell'Acqua A; Arduino PG; Pentenero M; Appendino P; Basano L; Ferrera FD; Fasciolo A; Caka M; Migliario M
Med Oral Patol Oral Cir Bucal; 2021 Jul; 26(4):e466-e473. PubMed ID: 33340073
[TBL] [Abstract][Full Text] [Related]
34. Incidence of and risk factors for medication-related osteonecrosis of the jaw in women with breast cancer with bone metastasis: a population-based study.
Hallmer F; Bjarnadottir O; Götrick B; Malmström P; Andersson G
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Sep; 130(3):252-257. PubMed ID: 32536575
[TBL] [Abstract][Full Text] [Related]
35. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
[TBL] [Abstract][Full Text] [Related]
36. Periosteal reaction of medication-related osteonecrosis of the jaw (MRONJ): clinical significance and changes during conservative therapy.
Soutome S; Otsuru M; Hayashida S; Yanamoto S; Sasaki M; Takagi Y; Sumi M; Kojima Y; Sawada S; Iwai H; Umeda M; Saito T
Support Care Cancer; 2021 Nov; 29(11):6361-6368. PubMed ID: 33884506
[TBL] [Abstract][Full Text] [Related]
37. Retrospective Analysis of Treatment Outcomes of Maxillary Sinusitis Associated with Medication-Related Osteonecrosis of the Jaw.
Otsuru M; Hayashida S; Morishita K; Murata M; Soutome S; Sasaki M; Takagi Y; Sumi M; Umeda M
Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742679
[TBL] [Abstract][Full Text] [Related]
38. Further development of the MRONJ minipig large animal model.
Otto S; Pautke C; Martin Jurado O; Nehrbass D; Stoddart MJ; Ehrenfeld M; Zeiter S
J Craniomaxillofac Surg; 2017 Sep; 45(9):1503-1514. PubMed ID: 28803745
[TBL] [Abstract][Full Text] [Related]
39. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
Giovannacci I; Meleti M; Manfredi M; Mortellaro C; Greco Lucchina A; Bonanini M; Vescovi P
J Craniofac Surg; 2016 May; 27(3):697-701. PubMed ID: 27092912
[TBL] [Abstract][Full Text] [Related]
40. Declining Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Cancer.
Sim IeW; Sanders KM; Borromeo GL; Seymour JF; Ebeling PR
J Clin Endocrinol Metab; 2015 Oct; 100(10):3887-93. PubMed ID: 26241323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]